PharmaVoice 100: Grant McFadden

< back

OncoMyx scientific founder, Dr. Grant McFadden, was recognized by leading industry magazine, PharmaVoice, for 30+ years of research on myxoma virus as a unique oncolytic immunotherapy to improve cancer treatment. Read the article to learn what keeps him up at night.